Rudolph Navari to Time Factors
This is a "connection" page, showing publications Rudolph Navari has written about Time Factors.
Connection Strength
0.028
-
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Invest. 2004; 22(3):383-8.
Score: 0.008
-
Comparison of the open skull and cranial window preparations in the study of the cerebral microcirculation. Microvasc Res. 1978 Nov; 16(3):304-15.
Score: 0.006
-
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis. Support Care Cancer. 1997 Jan; 5(1):31-7.
Score: 0.005
-
Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. Cancer Invest. 1997; 15(4):297-303.
Score: 0.005
-
Protein turnover in advanced lung cancer patients. Metabolism. 1993 Mar; 42(3):291-6.
Score: 0.004
-
Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats. Circ Res. 1980 Jan; 46(1):37-47.
Score: 0.002